Clinical trial

68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy

NCT07747493

Study summary

ClinicalTrials.gov

68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Gallium Ga 68 Gozetotide (68Ga-PSMA-11) Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Intervention Description: Integrated positron emission tomography/magnetic resonance imaging (PET/MRI) combines molecular imaging with high-resolution anatomical MRI to evaluate intraprostatic lesions Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhaseNA

Conditions

Prostate Cancer (Adenocarcinoma)unresolved

Localized Prostate Cancerunresolved

Interventions

Gallium Ga 68 Gozetotide (68Ga-PSMA-11)DRUG

Intervention Description: Integrated positron emission tomography/magnetic resonance imaging (PET/MRI) combines molecular imaging with high-resolution anatomical MRI to evaluate intraprostatic lesionsDIAGNOSTIC_TEST

Sponsors & collaborators

University Health Network, Torontolead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07747493 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.